Shanghai-listed stem cell storage service operator Zhongyuan Union Stem Cell Bio-engineering has partnered with China Yinhong Capital to launch an industry merger and acquisition (M&A) fund with a target of RMB5 billion (US$813 million), according to Zhongyuan’s official announcement. The two parties will set up an asset management firm, named Zhongyuan Investment, with registered capital […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.